Evidence map›Paper›PMID 42432267›Full record

ArticleParasitology research2026

Human cystic echinococcosis transmission dynamics in Iran, 1997-2040: modeling control strategies for public health planning.

Behrooz Ahmadi, Meysam Olfatifar, Leila Modarresnia, Anastasia Diakou, Mahdi Fakhar, Mehdi Pezeshgi Modarres, Kader Yildiz, Milad Badri

Abstract read
In one paragraph

Article in Parasitology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Behrooz AhmadiGastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Meysam OlfatifarGastroenterology and Hepatology Diseases Research Center, Qom University of Medical Sciences, Qom, Iran. ol.meysam92@gmail.com.
Leila ModarresniaMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Anastasia DiakouLaboratory of Parasitology and Parasitic Diseases, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, 54124, Greece.
Mahdi FakharGastroenterology and Hepatology Diseases Research Center, Qom University of Medical Sciences, Qom, Iran.
Mehdi Pezeshgi ModarresGastroenterology and Hepatology Diseases Research Center, Qom University of Medical Sciences, Qom, Iran.
Kader YildizFaculty of Veterinary Medicine, Department of Parasitology, Kirikkale University, Kirikkale, 71450, Türkiye.
Milad BadriMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran. badri22.milad@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic echinococcosis (CE) remains a significant public health burden in Iran, with humans serving as accidental dead-end hosts. This study assesses historical CE prevalence trends and projects future human CE burden under targeted intervention scenarios using mathematical modeling. We developed a dynamic Susceptible-Exposed-Inected-Recovered (SEIR) transmission model of CE in Iran, calibrated to historical human prevalence data (1997-2023). Univariate and bivariate sensitivity analyses were conducted to evaluate the influence of key parameters. Model projections to 2040 evaluated four intervention scenarios: a baseline scenario and three alternatives, targeting reductions in exposure rates and increases in case detection rates. Human CE prevalence declined from 3.90% (1997) to 2.20% (2023), representing a 43.49% reduction. Projected trends indicate further decline to 1.37% by 2040 (37.79% reduction from 2023). The 40% exposure reduction scenario achieved the lowest prevalence (1.16% in 2040; 47.31% reduction), while the combined 20% exposure reduction plus 20% detection rate increase scenario yielded 1.27% (42.54% reduction). Crucially, enhanced detection rate reduced long-term prevalence by shortening time-to-diagnosis (time from infection to diagnosis), accelerating case resolution without altering transmission dynamics. To accelerate Iran's successful CE control program toward timely elimination, a decisive strategy to reduce transmission at its source is paramount. Our modeling identifies a 40% reduction in the exposure rate as the most effective intervention to minimize prevalence by 2040. Enhancing early detection provides synergistic benefits, but targeted veterinary and environmental control must be the priority for a rapid and equitable outcome.

Indexed as

Communicable Disease ControlEchinococcosisAnimalsHumansIranModels, TheoreticalPrevalencePublic HealthHuman cystic echinococcosisIranPrevalence trendScenario analysisSEIR (susceptible-exposed-infected-recovered) model

Identifiers

PMID42432267
PMCPMC13638755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.